These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29471464)

  • 1. Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013.
    Cobey S; Gouma S; Parkhouse K; Chambers BS; Ertl HC; Schmader KE; Halpin RA; Lin X; Stockwell TB; Das SR; Landon E; Tesic V; Youngster I; Pinsky BA; Wentworth DE; Hensley SE; Grad YH
    Clin Infect Dis; 2018 Jul; 67(3):327-333. PubMed ID: 29471464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Zost SJ; Parkhouse K; Gumina ME; Kim K; Diaz Perez S; Wilson PC; Treanor JJ; Sant AJ; Cobey S; Hensley SE
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12578-12583. PubMed ID: 29109276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.
    Skowronski DM; Janjua NZ; De Serres G; Sabaiduc S; Eshaghi A; Dickinson JA; Fonseca K; Winter AL; Gubbay JB; Krajden M; Petric M; Charest H; Bastien N; Kwindt TL; Mahmud SM; Van Caeseele P; Li Y
    PLoS One; 2014; 9(3):e92153. PubMed ID: 24667168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).
    Skowronski DM; Sabaiduc S; Leir S; Rose C; Zou M; Murti M; Dickinson JA; Olsha R; Gubbay JB; Croxen MA; Charest H; Bastien N; Li Y; Jassem A; Krajden M; De Serres G
    Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Antibody Recognition of H3N2 Vaccine and Seasonal Influenza Virus Strains Based on Age, Vaccine Status, and Sex in the 2017-2018 Season.
    Ursin RL; Liu H; Powell HR; Westerbeck JW; Shaw-Saliba K; Sylvia KE; Fenstermacher KJ; Mehoke T; Thielen P; Rothman RE; Pekosz A; Klein SL
    J Infect Dis; 2020 Sep; 222(8):1371-1382. PubMed ID: 32496543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018.
    Belongia EA; Levine MZ; Olaiya O; Gross FL; King JP; Flannery B; McLean HQ
    Vaccine; 2020 Mar; 38(15):3121-3128. PubMed ID: 32145994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan.
    Sugaya N; Shinjoh M; Kawakami C; Yamaguchi Y; Yoshida M; Baba H; Ishikawa M; Kono M; Sekiguchi S; Kimiya T; Mitamura K; Fujino M; Komiyama O; Yoshida N; Tsunematsu K; Narabayashi A; Nakata Y; Sato A; Taguchi N; Fujita H; Toki M; Myokai M; Ookawara I; Takahashi T
    Euro Surveill; 2016 Oct; 21(42):. PubMed ID: 27784529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016/17 season in Denmark.
    Trebbien R; Fischer TK; Krause TG; Nielsen L; Nielsen XC; Weinreich LS; Lis-Tønder J; Skov MN; Christiansen CB; Emborg HD
    J Clin Virol; 2017 Sep; 94():1-7. PubMed ID: 28697450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season.
    Levine MZ; Martin ET; Petrie JG; Lauring AS; Holiday C; Jefferson S; Fitzsimmons WJ; Johnson E; Ferdinands JM; Monto AS
    J Infect Dis; 2019 May; 219(12):1904-1912. PubMed ID: 30721982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort.
    Kissling E; Pozo F; Buda S; Vilcu AM; Gherasim A; Brytting M; Domegan L; Gómez V; Meijer A; Lazar M; Vučina VV; Dürrwald R; van der Werf S; Larrauri A; Enkirch T; O'Donnell J; Guiomar R; Hooiveld M; Petrović G; Stoian E; Penttinen P; Valenciano M;
    Euro Surveill; 2019 Nov; 24(48):. PubMed ID: 31796152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H3N2 Mismatch of 2014-15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps.
    Xie H; Wan XF; Ye Z; Plant EP; Zhao Y; Xu Y; Li X; Finch C; Zhao N; Kawano T; Zoueva O; Chiang MJ; Jing X; Lin Z; Zhang A; Zhu Y
    Sci Rep; 2015 Oct; 5():15279. PubMed ID: 26472175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains.
    Galli C; Orsi A; Pariani E; Lai PL; Guarona G; Pellegrinelli L; Ebranati E; Icardi G; Panatto D
    Expert Rev Vaccines; 2020 Jan; 19(1):115-122. PubMed ID: 31875483
    [No Abstract]   [Full Text] [Related]  

  • 15. An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children.
    Florek KR; Campos LM; Braun KM; McLean HQ; King JP; Flannery B; Belongia EA; Friedrich TC
    Vaccine; 2018 Jan; 36(5):758-764. PubMed ID: 29249543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season.
    López-Labrador FX; Natividad-Sancho A; Pisareva M; Komissarov A; Salvatierra K; Fadeev A; Moya A; Grudinin M; Díez-Domingo J; Afanasieva O; Konovalova N; Sominina A; Puig-Barberà J
    J Clin Virol; 2016 Nov; 84():32-38. PubMed ID: 27690141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interim estimates of divergence date and vaccine strain match of human influenza A(H3N2) virus from systematic influenza surveillance (2010-2015) in Hangzhou, southeast of China.
    Li J; Zhou YY; Kou Y; Yu XF; Zheng ZB; Yang XH; Wang HQ
    Int J Infect Dis; 2015 Nov; 40():17-24. PubMed ID: 26417878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons.
    Monamele GC; Vernet MA; Njankouo MR; Victoir K; Akoachere JF; Anong D; Njouom R
    PLoS One; 2017; 12(9):e0184411. PubMed ID: 28877235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.
    Kishida N; Fujisaki S; Yokoyama M; Sato H; Saito R; Ikematsu H; Xu H; Takashita E; Tashiro M; Takao S; Yano T; Suga T; Kawakami C; Yamamoto M; Kajiyama K; Saito H; Shimada S; Watanabe S; Aoki S; Taira K; Kon M; Lin JH; Odagiri T
    Clin Vaccine Immunol; 2012 Jun; 19(6):897-908. PubMed ID: 22492743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
    Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
    Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.